Apotex to acquire Arrow Pharmaceuticals from Strides Pharma Science.

Apotex, a Canadian pharmaceutical corporation, to acquire Arrow Pharmaceuticals, the Australian operating business of Strides, held through Singapore, Apotex, a Canadian pharmaceutical corporation, from Strides Pharma Science, an Indian pharmaceutical company. "The strong relationships we have built with our much-valued pharmacy customers to date will be fundamental to our joint success. Importantly, the proposed merger will also provide Australian pharmacists, their patients and consumers alike with ongoing access to a diverse range of almost 500 low-cost medicines, and permit the expansion of our current product ranges, including OTC, vitamins and practitioner-only products," Apotex Managing Director, Asia Pacific, Roger Millichamp.